anti-Lung Carcinoma antibody (CHALU2)
Cancers that derived from epithelium of the lung are called lung carcinoma. Each year, lung carcinoma causes over one million of deaths worldwide. Based on the size of cancer cells, lung carcinoma is grouped into two types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC is strongly associated with smokers. SCLC grows and metastases very fast and responds to surgical resection poorly. NSCLS includes squamous cell carcinoma, adenocarcinoma and large cell carcinoma. Antibodies against lung carcinoma can be used as a guiding tool in bio-missile cancer therapy strategy.
Do you have any questions about this product?
Order your product by email
Productname
anti-Lung Carcinoma antibody (CHALU2)
ARG10082100
By filling out this form, you are placing an order by e-mail. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.
Request a sample
Productname
anti-Lung Carcinoma antibody (CHALU2)
ARG10082100
By filling out this form, you request a sample. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.
Are you looking for specific products, alternatives or documentation?
